0001493152-26-006969
SEC filingPalatin Technologies, Inc. reported a net loss of $7.3 million for Q2 2026 (period ending December 31, 2025), consistent with its loss from operations. The company generated minimal revenue of $116,000 from collaboration and license agreements, while operating expenses totaled $7.4 million, primarily driven by research and development ($4.3 million) and general and administrative costs ($3.1 million). A significant non-operating gain of $2.5 million from the sale of Vyleesi partially offset these expenses. The balance sheet shows total assets of $17.9 million, with cash and cash equivalents of $14.5 million, and stockholders' equity of $11.5 million. Cash flow from operations was negative $6.4 million, but financing activities provided $18.4 million, primarily from the sale of common stock and warrants ($16.9 million) and warrant exercises ($1.1 million), resulting in a net cash increase of $11.9 million. No prior period QoQ comparison data is provided in the filing.
Palatin Technologies reported a net loss of $7.3 million for the quarter ended December 31, 2025. This loss was driven by operating expenses of $7.4 million, which included research and development costs of $4.3 million and general and administrative expenses of $3.1 million. Revenue was minimal at $116,000 from collaboration and license agreements. The company recorded a gain of $2.5 million from the sale of Vyleesi, which reduced the net loss. Other income included $65,000 from investments and a $12,000 foreign currency transaction gain. Basic and diluted net loss per common share were both $3.00, based on 2.5 million weighted average shares outstanding. No prior quarter figures are provided for comparison.
The filing does not disclose segment breakdowns, geographic mix, or detailed revenue growth drivers. The only revenue figure explicitly stated is $116,000 from collaboration and license agreements. There is no information on product sales, service revenue, or other income streams beyond the noted collaboration and license amount. The document lacks comparative data from previous quarters or years for revenue analysis.
The filing does not provide gross profit, gross margin, operating margin, or related profitability metrics. Operating loss was $7.3 million, matching the net loss. Cost structure details are limited to the disclosed operating expenses: research and development ($4.3 million) and general and administrative ($3.1 million). No margin percentages or trends are calculable from the provided data, as revenue and cost of goods sold figures for margin analysis are not available.
Net cash used in operating activities was $6.4 million, primarily due to the $7.3 million net loss, adjusted for non-cash items like depreciation ($29,000) and stock-based compensation ($698,000). Investing activities used $13,000, mainly from property purchases. Financing activities provided $18.4 million, from stock and warrant sales ($16.9 million net) and warrant exercises ($1.1 million). Cash and cash equivalents increased by $11.9 million to $14.5 million. Total assets are $17.9 million, with current assets of $17.5 million. Liabilities total $6.5 million, mostly current ($6.3 million). Stockholders' equity is $11.5 million, with an accumulated deficit of $461.7 million. No debt levels beyond lease liabilities are disclosed.
The filing does not include management guidance, strategic priorities, or specific risk factors beyond standard SEC disclosures. No forward-looking statements, revenue projections, or operational plans are provided in the document content or XBRL data. The analysis is limited to the historical financial results for the quarter ended December 31, 2025.